InspireMD, Inc.
NSPR
$0.73
-$0.05-5.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 122.24% | 61.57% | 39.39% | 2.24% | 1.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 122.24% | 61.57% | 39.39% | 2.24% | 1.19% |
| Cost of Revenue | 119.16% | 33.04% | 18.84% | 4.05% | 1.48% |
| Gross Profit | 135.27% | 151.60% | 108.70% | -5.44% | 0.00% |
| SG&A Expenses | 28.71% | 59.35% | 107.22% | 83.01% | 51.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.77% | 34.61% | 51.62% | 47.98% | 45.54% |
| Operating Income | -21.97% | -29.01% | -54.23% | -57.62% | -54.57% |
| Income Before Tax | -22.60% | -28.34% | -61.06% | -66.28% | -58.79% |
| Income Tax Expenses | -- | 6.78% | -- | -- | -- |
| Earnings from Continuing Operations | -22.60% | -28.20% | -61.06% | -66.28% | -58.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.60% | -28.20% | -61.06% | -66.28% | -58.79% |
| EBIT | -21.97% | -29.01% | -54.23% | -57.62% | -54.57% |
| EBITDA | -21.71% | -28.51% | -53.99% | -57.58% | -54.69% |
| EPS Basic | 26.87% | 23.88% | -6.07% | -16.97% | -8.71% |
| Normalized Basic EPS | 26.86% | 23.78% | -6.08% | -16.98% | -8.81% |
| EPS Diluted | 26.87% | 23.88% | -6.07% | -16.97% | -8.71% |
| Normalized Diluted EPS | 26.86% | 23.78% | -6.08% | -16.98% | -8.81% |
| Average Basic Shares Outstanding | 67.63% | 68.48% | 51.89% | 42.16% | 46.00% |
| Average Diluted Shares Outstanding | 67.63% | 68.48% | 51.89% | 42.16% | 46.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |